Abnormal signaling through this pathway relates to several important aspects of cancer prognosis and treatment, including tumorigenesis, progression, and therapeutic resistance, which suggests prognostic relevance of PIK3CA mutations for patients with mBC [9–11]. The gene discussed is PIK3CA; the disease is cancer.